Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS(2025) Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia Clin Cancer Res(in press) DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050
Taskén K, Mahon P(2025) Accelerating precision oncology by converging pragmatic trials and real-world evidence Nat Rev Drug Discov(in press) DOI 10.1038/d41573-025-00047-5, PubMed 40082591
Kelly MP, Nikolaev VO, Gobejishvili L, Lugnier C, Hesslinger C, Nickolaus P, Kass DA, Pereira de Vasconcelos W, Fischmeister R, Brocke S, Epstein PM, Piazza GA, Keeton AB, Zhou G, Abdel-Halim M, Abadi AH, Baillie GS, Giembycz MA, Bolger G, Snyder G, Tasken K, Saidu NEB, Schmidt M, Zaccolo M, Schermuly RTet al.(2025) Cyclic nucleotide phosphodiesterases as drug targets Pharmacol Rev, 77(3), 100042(in press) DOI 10.1016/j.pharmr.2025.100042, PubMed 40081105
Room: K04:061 
